H.C. Wainwright analyst Douglas Tsao maintains $Alkermes (ALKS.US)$ with a hold rating, and maintains the target price at $37.
According to TipRanks data, the analyst has a success rate of 45.4% and a total average return of 13.3% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Alkermes (ALKS.US)$'s main analysts recently are as follows:
Alkermes' recent quarterly performance was consistent with expectations, and the company maintained its outlook for 2024. However, during the earnings discussion, attention was drawn to projections that 2025 EBITDA would exceed $200M, contrasting with a consensus of $400M. This difference in EBITDA expectations seems to stem from the anticipated decline of high-margin royalty incomes and, to a smaller degree, increased expenditure.
Alkermes' Q3 results presented an operating performance in line with expectations, reflecting a mix of positive and negative factors. The company is intensifying its investment focus on ALKS-2680 and its orexin-2 receptor agonist pipeline, which may moderate short-term profitability. Nonetheless, there is optimism regarding the long-term value generation prospects of ALKS-2680.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
H.C. Wainwright分析師Douglas Tsao維持$阿爾凱默斯 (ALKS.US)$持有評級，維持目標價37美元。
根據TipRanks數據顯示，該分析師近一年總勝率為45.4%，總平均回報率為13.3%。
此外，綜合報道，$阿爾凱默斯 (ALKS.US)$近期主要分析師觀點如下：
阿爾凱默斯最近一個季度的表現符合預期，該公司維持了對2024年的展望。然而，在盈利討論期間，人們開始關注2025年的稅前利潤超過20000萬美元的預測，與40000萬美元的一致看法形成鮮明對比。對稅前利潤的預期差異似乎源自高利潤的特許收入預期下降以及支出增加這兩個因素。
阿爾凱默斯第三季度的業績與預期一致，反映了積極和消極因素的結合。該公司正在加大對ALKS-2680和其促富奧睡眠素2受體激動劑管線的投資重點，這可能會減少短期利潤。儘管如此，人們對ALKS-2680的長期價值創造前景持樂觀態度。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
